Actavis in North America
Approximately one quarter of Actavis’ sales are generated in the United states, Actavis' single largest market. Three of the Group’s highest selling products are sold in the US market.
Manufacturing sites in North America:
Actavis has manufacturing sites for solid, liquid, and semi-solid dosage forms in the United States:
Elizabeth, NJ: Solid-oral-dose facility for tablets and capsules supporting a broad therapeutic range. Core competency in modified-release products.
Totowa, NJ: Actavis has two solid-oral dose manufacturing facilities in Totowa, in Little Falls and at Riverview Drive, in addition to a packaging facility at Taft Road. The Riverview facility opened in 2007, and will provide a considerable increase to the Company’s solid-oral-dosage capacity when in full operation.
Lincolnton, NC: A growing production site for creams, ointments, liquids, and suppository products serving the OTC (over-the-counter), branded, and Rx markets in the US. Leading supplier of first aid, feminine hygiene, hydrocortisone, anti-fungal, and permethrin products for private-label and own-label series.
Contact information for Actavis in the United States